Clinical Trial Finds Antibody Treatment Improves EoE Symptoms and Pathology in Young Adults and Adolescents
Published on in CHOP News
A study involving CHOP researchers found that a weekly dose of dupilumab, a monoclonal antibody, led to a reduction of symptoms and tissue improvement in young adults and adolescents with eosinophilic esophagitis (EoE).